MyBCTeam

These results can feel overwhelming, but here's a plain-language breakdown of what each part means. Remember, your care team will use all of this together to plan your treatment — no single finding tells the whole story.

What type of cancer was found
- You have invasive ductal carcinoma with lobular features — meaning it Show Full Answer

These results can feel overwhelming, but here's a plain-language breakdown of what each part means. Remember, your care team will use all of this together to plan your treatment — no single finding tells the whole story.

What type of cancer was found:
- You have invasive ductal carcinoma with lobular features — meaning it started in the milk ducts but has begun moving into surrounding breast tissue, with some characteristics of lobular cancer
- There is also lobular carcinoma in situ (LCIS) present, which is a non-invasive finding in the same area Grade (Nottingham Score: 7/9 = Grade 2):

The scoring system combines three features, each scored 1–3:

- Glandular/tubular differentiation: 3 — the cells form fewer normal-looking tube structures
- Nuclear pleomorphism: 3 — the cell centers look quite different from normal cells
- Mitotic rate: 1 — the cells are dividing relatively slowly

A total score of 7 puts this at Grade 2, meaning moderately differentiated — not the slowest-growing, but not the most aggressive either. Tumor size & spread:
- The invasive area measured 5.7mm in this biopsy sample — quite small
- No lymphovascular invasion was identified, meaning no cancer was seen in nearby blood or lymph vessels — this is a positive finding Receptor status (these guide treatment options):

- Estrogen receptor (ER): Positive — the cancer cells respond to estrogen, meaning hormone-blocking therapy is likely an option
- Progesterone receptor (PR): Negative — no progesterone response detected
- HER2: Equivocal (2+) — this is an in-between result; additional testing (called ISH or FISH) will likely be ordered to clarify whether HER2-targeted therapy is appropriate
- Ki-67: 25% — this measures how actively cells are dividing; 25% is considered intermediate to moderately elevated Calcifications & necrosis:
- Calcifications were found associated with the invasive cancer — this is common and was likely visible on imaging
- Necrosis (areas of dead cells) was noted within the LCIS component

Overall, there are some encouraging signs here — small tumor size, no lymphovascular invasion, and a moderate grade. That said, the equivocal HER2 result will need follow-up testing before your full treatment picture is clear.

Please bring all of these questions to your oncologist — they'll be able to put everything together and explain what it means specifically for your situation. You don't have to decode this alone. 💙

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

How (and Why) To Read Your Breast Cancer Pathology Report

Mammogram Biopsy: What To Expect